2007 Chrysler Crossfire Roadster 3.2l V6 18v Manual Only 54k Miles! on 2040-cars

Auto blog

Dodge not being dropped by Chrysler, CEO reaffirms

Dodge isn't going anywhere. Despite some rumor and speculation over the future of the crosshair grille and the cars that wear it, Dodge brand boss, Tim Kuniskis, sat down with TheDetroitBureau.com, explaining that the marque isn't going anywhere. His sentiments echo those of SRT boss Ralph Gilles, who told a group of enthusiasts in July that "Dodge is here to stay!"
Dodge's death won't be "a part of a master plan to consolidate brands," Kuniskis told TheDetroitBureau.com. Instead, the brand, which is ultimately under the command of Fiat/Chrysler CEO, Sergio Marchionne, will likely ditch some of its badge-engineered models, like the Dodge Grand Caravan. A more focused Dodge, which was something Gilles has already hinted at, will likely see it exploring areas of the market that haven't been exploited by other Chrysler brands.
Kuniskis, not surprisingly, wasn't willing to delve into any detailed product plans, telling TDB that the size of the brand's lineup "remains to be seen." Regardless of how big the brand actually ends up being (it is presently Chrysler's volume brand - and not by a little), hopefully the statements from Kuniskiss can put the rumors of a Dodge closure to bed.

Chrysler reportedly to drop 300 sedan, build Portal millennial minivan

Automotive News Canada pointed its divination stick at Chrysler as part of its Future Product Pipeline series. The publication dug up two revelations, one being that the Chrysler 300 has two more years to live, ending production come 2020. The article said nothing about the 300's platform twin, the Dodge Charger. The death of the 300 would leave the Pentastar brand with just one offering, the Pacifica minivan. AN Canada's other revelation was Chrysler would allay that fate by putting the "six-passenger multi-purpose" Portal concept into production for 2020. The automaker that wants to be known for its people haulers introduced the Portal concept at the 2017 Consumer Electronics Show. The big bang at the time was the Portal having been designed by millennials in Chrysler's design department, specifically for millennial buyers. Feature bait for the confounding demographic included facial and voice recognition so the Portal knew who was in the car and could tailor the driving environment and cockpit to their tastes; a panoramic dashboard; a configurable interior so the owner can create space where needed, up front or in the cargo area; vehicle-to-vehicle and vehicle-to-infrastructure tech; upgradeable Level 3 autonomy; a retractable aviation-like steering wheel; and customizable light signatures. We didn't get many specs on the show car, but the all-electric powertain employed a 100-kWh lithium-ion battery, had a range of at least 250 miles, and could restore 150 of those miles in 20 minutes hooked up to a DC fast charger. Reasonable specs for a real vehicle. It wouldn't be an outrageous move for Chrysler to create a production version of the Portal. When the concept came to the 2018 Detroit Auto Show, former Fiat Chrysler CEO Sergio Marchionne told media he intended to roll out the "fifth generation" of family cars — the next evolution of the wagon-minivan-SUV-crossover progression — and he expected the Portal or something similar to make production at some point. The Detroit News predicted we'd get a Portal sometime after 2018. Tim Kuniskis, then head of FCA passenger cars in North America, said the company viewed the Portal as that fifth-gen product and "the future of family transportation." On top of that, the designers based the front-wheel-drive Portal on the Pacifica's platform, and Marchionne was vocal in his desire for another retail product on that architecture. He had said, "I need another minivan.

Fiat Chrysler says it did not know about Marchionne's illness

ZURICH/MILAN — Fiat Chrysler said it knew nothing about the medical condition of Sergio Marchionne after a Swiss hospital said on Thursday it had been treating the deceased chief executive for more than a year. "Due to medical privacy, the company had no knowledge of the facts relating to Mr. Marchionne's health," a Fiat Chrysler spokesman said. Questions have been raised about how long Marchionne, who died on Wednesday, was ill and how much the company knew before it made the situation public. Marchionne rescued Fiat and Chrysler from bankruptcy after taking the wheel of the Italian carmaker in 2004 and he multiplied Fiat's value 11 times through 14 years of canny dealmaking. He was due to step down at FCA in April next year. "The company was made aware that Mr. Marchionne had undergone shoulder surgery and released a statement about this," the spokesperson said. "On Friday, July 20, the company was made aware with no detail by Mr. Marchionne's family of the serious deterioration in Mr. Marchionne's condition and that as a result he would be unable to return to work. The company promptly took and announced the appropriate action the following day." Asked whether the scope of the statement included the board and the chairman, the company declined to comment. In emailed comments, Marchionne's family confirmed the companies had not been aware of his health conditions. "At the end of last week FCA was made aware Sergio Marchionne would no longer be able to return to work without mentioning any further details," the family said. The announcement of the death of Marchionne, 66, one of the auto industry's most tenacious and respected CEOs, drew tributes from rivals and tears from his closest colleagues on Wednesday. University Hospital Zurich said earlier on Thursday Marchionne had been treated for a serious illness for more than a year before his death. Marchionne had fallen gravely ill after what the company had described as shoulder surgery at a Zurich hospital. He was replaced as chief executive last weekend after Fiat Chrysler (FCA) said his condition had worsened. "Mr. Sergio Marchionne was a patient at USZ. Due to serious illness, he had been the recipient of recurring treatment for more than a year," the hospital said in a statement. "Although all the options offered by cutting-edge medicine were utilized, Mr.